Cardiff and Vale University Health Board

South Wales, Welsh Region

Management of High Grade Dysplasia patients

Welsh Region National
Number of High Grade Dysplasia patients in audit N/A 1448
Welsh Region National
Method of Diagnosis
– First diagnosis confirmed by second pathologist N/A 86.9%
Treatment planning
– HGD plan discussed at MDT N/A 87.9%
– Treatment plan for active treatment N/A 81.1%
First treatment
– Endoscopic therapy (such as endoscopic resection) N/A 73.8%
– Surveillance N/A 11.0%

Management of oesophago-gastric cancer patients

Time period: 2017-2019
Organisation National
Number of oesophago-gastric (OG) cancer patients in audit 128 20528
Case ascertainment for OG cancer (%) 65-74%
Method of Diagnosis
– Patients diagnosed after an emergency admission**
** Percent figure accounts for differences in mix of patients across organisations
16 13.8% 13.3%
– Patients with referral source reported as unknown 0 0.0% 1.8%
Pre-treatment staging of cancer
– Patients having staging CT scan recorded 122 95.3% 86.9%
Treatment planning
– Patients having a plan for curative treatment 45 35.2% 38.5%
– Patients having a plan for non-curative treatment 83 64.8% 61.5%
– Patients with non-curative plans having chemotherapy or radiotherapy 49 59.0% 48.2%

Outcomes for OG cancer patients who have curative surgery

Time period: 2016-2019
Organisation National
Number of patients having surgery 89 6273
Length of stay, median (days) 11 11
Operations in which 15 or more lymph nodes were examined (%) 78.5% 86.6%
30-day postoperative mortality (%) 0.0% 1.7%
90-day postoperative mortality (%) 1.1% 3.3%
Oesophageal surgery
Number of patients having oesophageal surgery 41 N/A
Oesophageal patients with positive longitudinal margins (%) 4.5% 4.2%
Oesophageal patients with positive circumferential margins (%) 14.5% 24.2%
Gastric surgery
Number of patients having gastric surgery 48 N/A
Gastric patients with positive longitudinal margins (%) 12.0% 8.1%

Compare trust outcomes

Download this data as a PDF